Form 4: Korro Bio Director Sells Shares
Insider Transaction (Form 4)
Jean Francois Formela, a Director of Korro Bio, Inc., sold 300 shares of common stock on August 26, 2026 for $13.96 per share.
Summary
- Open-market sale: disposed of 249 Common Stock at $13.96 ($3,476) on August 26, 2026; holds 680,948 after (Indirect).
- Open-market sale: disposed of 51 Common Stock at $13.96 ($712) on August 26, 2026; holds 141,002 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,188 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jean Francois Formela — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market sale | Common Stock | 249 | $14 | $3.5K | 680,948 |
| 2026-08-26 | Open-market sale | Common Stock | 51 | $14 | $712 | 141,002 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market sale (249 shares) |
| 2026-08-26 | Open-market sale (51 shares) |
Keywords
insider transaction, Form 4, KRRO, Korro Bio, Inc., bearish, Jean Francois Formela
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.